Description

The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021.

Resources

Name	Format	Description	Link
Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/conducting-clinical-trial/predictability-proposal-records-retention-notice.html
Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/liste-essais-cliniques-autorise/previsibilite-proposition-conservation-registres-avis.html

Tags

Topics

Categories